PREVECEUTICAL - Key Persons
Job Titles:
- Member of the Advisory Board
Mr. Bahl brings over 20 years of experience in pharmaceutical marketing and clinical development. He is the CEO and founder of RAS LSS, a boutique healthcare consulting group based in Germany providing strategic guidance to biotechnology and pharmaceutical companies on franchise and product strategy, clinical development and commercialization.
Mr. Bahl, who worked as Director of Competitive Intelligence at Novartis Pharma AG and as Senior Consultant for Janssen Research and Development, is known for his entrepreneurship, creativity and is a passionate speaker for innovations in healthcare. He has significant leadership experience across several therapeutic areas, including oncology and biosimilars.
Job Titles:
- Executive Assitant & Office Manager
Ms. Ortega is a professional currently studying commerce while gaining valuable experience in the hospitality and marketing industries over the past two years. Ms. Ortega excels at streamlining operations and optimizing marketing strategies, all while serving as an accomplished executive assistant.
Mr. Ballantyne has extensive executive leadership experience and has spent the last 20 years as a public and private company Chief Financial Officer in the healthcare industry. He was most recently the CFO of OncXernaTherapeutics Inc. where he worked to advance partnering opportunities for the company's biomarker program. Prior to OncXerna, Ballantyne was CFO at Orchestra BioMed Inc. where he assisted with the closing of two equity financing rounds with proceeds of $57 million. At Orchestra, he also helped close a global partnership deal valued at more than $200 million.
Job Titles:
- Advisor
- Consultant
- Member of the Advisory Board
Dr. Shetty has extensive pharmaceutical experience leading commercial and supply chain operations and a significant educational background, including a Ph.D. in Metallurgy from Trinity College at Cambridge University. Dr. Shetty spent 36 years at Johnson & Johnson ("J&J") in a wide range of global roles. From 2007 to 2012, he served as Corporate Vice President, Enterprise Supply Chain, reporting to the CEO and was responsible for the transformation and optimization of J&J's supply chain. In addition, from 2004 to 2012, he served as chairman of Janssen Pharmaceutical.
In recognition of his unique services as a business leader, Dr. Shetty was awarded the Right Honourable Sir and Title of Baron by King Albert II of Belgium in 2008 and the Life-Time Achievement Award by India in 2010.
has been appointed to the Board, the Board's audit committee, and the corporate governance and nominating committee. Dr. Olofsson is a business entrepreneur with a background in development, clinical trials, and commercialization.
Dr. Olofsson is an accomplished biophysicist with 12 years of laboratory research experience in academia, and 3 years working in the private sector as scientific support and equipment sales. She successfully advances science by providing counsel and training to the scientific community, contributing to executing strategic marketing plans by working in conjunction with the sales team members to identify and qualify sales leads through technical discussions. Dr. Olofsson closely collaborates with corporate strategic decision-making processes to penetrate new market applications to increase return on investment.
Based at the University of Queensland's (UQ) Pharmacy Australia Centre of Excellence (PACE), Dr. Parekh also holds adjunct positions at the National University of Singapore, and Manipal University, India. Dr. Parekh heads the Drug/Gene Delivery Group at PACE-UQ with his team developing highly innovative and translational medicine delivery systems in-conjunction with physicians whose expertise span cancer, obesity-&-diabetes, macular disease, infectious disease and traditional (Chinese) medicine.
Job Titles:
- Public Officer and Director of Its Subsidiary Company
Job Titles:
- Two Independent Directors
Two independent directors, Keith Anderson and Mark Lotz, joined the Board of Directors, both with extensive public sector experience. Dr. Mak Jawadekar was appointed as President and Chief Science Officer; he will be key to finding strategic partners to move these programs forward. With these additions, PreveCeutical will benefit from years of insight, judgment and counsel and further strengthen its corporate governance.
Job Titles:
- Chief Science Officer
- President
Dr. Mak Jawadekar worked at Pfizer Inc. in Groton-New London, Connecticut, for 28 consecutive years. His most recent position was as a Director of Portfolio Management at Pfizer Inc. He was responsible for Drug Delivery Technology Assessment function involving external ‘Drug Delivery' technologies. He has extensive experience in creating and cultivating external partnerships and alliances for drug delivery technologies. He began his professional career at Pfizer Central Research in early 1982, after having completed his Ph.D. in Pharmaceutics at the University of Minnesota.
Job Titles:
- Director
- Principal With Somerset CPA 's P.C. Kathy
Ms. Kathleen Rokita has been appointed to the Company's Board of Directors. She is a CPA and Principal of Somerset CPA's P.C. She is a finance, operations, and strategy-focused executive with extensive experience with large medical groups.
Ms. Rokita is a CPA and Principal with Somerset CPA's P.C. Kathy is a finance, operations, and strategy-focused executive having extensive experience with large medical groups. Her involvement includes business development, information reporting, analytics, and improvements in financial performance and operational processes. She has a background in treasury management, budgeting, as well as mergers and acquisitions. Kathy has been appointed to PreveCeutical's audit committee. Kathy also selflessly dedicates time to volunteering as a board member for St. Vincent Hospital Foundation and Angelman Syndrome Foundation, where she served as Treasurer and President of the Board of Directors.
Job Titles:
- Head of Artificial Intelligencer
Mr. Sadler is an accomplished professional in the field of artificial intelligence; as the Head of AI, his primary goal is to harness the power of AI and data-driven insights to advance biotechnology research and unlock novel therapeutic opportunities. With a strong foundation in machine learning, natural language processing, and big data analysis, he is committed to developing innovative AI frameworks, streamlining research workflows, and fostering a culture of collaboration and innovation within the organization. Shawn's passion for creating interactive data visualizations and promoting accessible, data-driven decision-making will contribute to PreveCeutical's mission of improving human health through cutting-edge research and ground-breaking solutions.
Job Titles:
- Chairman
- Chief Executive Officer
- Chief Financial Officer
Mr. Van Deventer is an experienced business person and corporate director. Specialising in international corporate relations and business development over the last thirty years, Mr. Van Deventer has focused on launching small to medium-sized companies into the public markets in Canada, the United States and Europe. He has also owned and operated private businesses.